Han JW, Zhong Y, Zhong J, Zeng WJ, et al. First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis. PLoS One 2025;20:e0325808.
PMID: 40493606